As a world leader in treating both acute and chronic immune thrombocytopenia (ITP) and other inherited and acquired platelet function disorders, the Platelet Function Disorders Program at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center provides comprehensive care for children and adolescents.
Dana-Farber/Boston Children’s is an integrated pediatric hematology and oncology partnership between Dana-Farber Cancer Institute and Boston Children’s Hospital. We offer, in one specialized program, the full spectrum of services that are needed for diagnosis, treatment, and ongoing care of even the rarest and hard-to-treat conditions.
Our expertise in platelet function disorders
Dana-Farber/Boston Children's patients have access to the broadest set of pediatric specialists available. The breadth of our expertise allows us to assemble a team of specialists to meet the specific needs of the patient.
At the core of our treatment team are pediatric hematologists with expertise in pediatric platelet function disorders and an experienced nursing staff and social workers, as well as access to expert pediatric subspecialists. Our team also includes dedicated researchers who are seeking to better understand and treat pediatric platelet disorders.
Platelet function disorders research
We are a world leader in research into platelet function disorders and an active member of the Center for Platelet Research Studies, an internationally recognized multidisciplinary center for the study of platelet function by state of the art methods. This center undertakes basic, translational, and clinical research, including clinical trials of drugs, devices, and tests. Search for current platelet function disorders clinical trials.